OpenAI acquires Orchestra Bio
19h
- Published
- Collected
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
overfeed.news indexes and links. We publish a short excerpt — the full article stays at OpenAI News.
More from OpenAI News
Log in to follow this source
Franchisee reconciles cash in 94% less time with ChatGPT Work
An independent Schlotzsky’s and Cinnabon franchisee cut menu repricing time by 95% and built a workflow that could free up $100K in cash flow.
Advancing Coding in Low-Resource Programming Languages
Learn how OpenAI is improving ChatGPT across low-resource programming languages, with new evaluations for software engineering, SQLite, and COBOL migration.
How Itaú is building generative AI for its entire customer base
With ia.i, a conversational interface, and the IARA governance platform, Itaú is applying its AI First strategy to customers and employees — in one of Brazil’s most regulated sectors.
Benefit Street Partners answers questions faster with Codex
Anant Kumar builds tools to compare loan valuations and analyze credit agreements, using Codex for code review and faster follow-ups.